Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms
A phase 2 trial of Carmustine, Mercaptopurine and Streptozocin in Oligodendroglioma, IDH-mutant and 1p/19q-codeleted and Glioma & glioblastoma, run by Emory University, completed.
Overview
Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms is a phase 2 interventional study registered as NCT00004688 by Emory University, with 35 participants recorded, started 1996-08. Interventions recorded: carmustine, mercaptopurine, streptozocin. Conditions recorded: Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Mixed Gliomas, Glioblastoma Multiforme, Recurrent Brain Tumor.
Linked to the drug Streptozocin because the registry names it among its interventions and Oligodendroglioma, IDH-mutant and 1p/19q-codeleted and Glioma & glioblastoma among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialCapecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors
Shares Streptozocin and the tag pipeline.
- TreatmentSafusidenib
Shares Oligodendroglioma, IDH-mutant and 1p/19q-codeleted, Glioma & glioblastoma and the tag pipeline.
- TrialSurgery, Radiation Therapy, and Chemotherapy With or Without Photodynamic Therapy in Treating Patients With Newly Diagnosed or Recurrent Malignant Supratentorial Gliomas
Shares Carmustine and the tag pipeline.
- TrialInjection of Active Allogeneic Natural Killer Cells in Patients With Gliomas
Shares Glioma & glioblastoma and the tag pipeline.
- TrialA Phase 1/2 Study of the Safety and Tolerability of MT-125 in GBM Patients
Shares Glioma & glioblastoma and the tag pipeline.
- TrialA Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of JL15003 Injection in Patients With Recurrent Glioblastoma (rGBM)
Shares Glioma & glioblastoma and the tag pipeline.
- TrialA Study of HF1K16 Combined With Bevacizumab in Patients With Recurrent or Progressive Glioma
Shares Glioma & glioblastoma and the tag pipeline.
- TrialA Phase 1b/2, Multicenter, Open-label Study of ACP-196 in Subjects With Recurrent Glioblastoma Multiforme (GBM)
Shares Glioma & glioblastoma and the tag pipeline.